Cara Therapeutics Inc.

(CARA) Trade

By |

Profile

Cara Therapeutics is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Contact Information

Website: www.caratherapeutics.com
Email: Jesse@sternir.com
Main Phone: +1 203 406-3700
Address: 107 Elm Street, 9th Floor
Address 2: 4 Stamford Plaza
State: CT
City / Town: Stamford
Country: USA
Postal Code: 06902

Issuer Information

Exchange: NSD
CEO: Derek T. Chalmers
Employees: 37
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 15.54 $ -0.16 (-1.02%)
Last Price 15.54 Change $ -0.16 Change % -1.02 Tick N/A
Bid 15.52 Bid Size 200.00 Ask 17.10 Ask Size 100.00
Open 15.88 High 16.00 Low 15.46 Prev Close 15.70
Last Trade Volume 449,803 52 Wk Hi 24.30 52 Wk Low 11.46
Market Cap 613 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 39,446,757.00 EPS (TTM) -1.97 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 17
Number of Buys 0 5
Number of Sells 2 12
Net Activity -12000 -287900
Last 10 Buys Shares
Habib Kairouz 1,000
Habib Kairouz 1,000
Martin A. Vogelbaum 1,000
Habib Kairouz 1,000
Martin A. Vogelbaum 1,000
Josef Schoell 1,000
Joseph Stauffer 1,000
Martin A. Vogelbaum 1,000
Last 10 Sell Shares
Frederique Menzaghi 1,000
Frederique Menzaghi 1,000
Derek T. Chalmers 1,000
Frederique Menzaghi 1,000
Frederique Menzaghi 1,000
Derek T. Chalmers 1,000
Derek T. Chalmers 1,000
Frederique Menzaghi 1,000
Derek T. Chalmers 1,000
Frederique Menzaghi 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 27 27 27 27
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 24.4 24.4 25 24.4
Standard Deviation 2.88 2.88 3.08 2.88
Date of Most Recent Estimate 05/29/18 05/29/18 05/23/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1